AGP
IRON icon

Artia Global Partners’s Disc Medicine IRON Stock Holding History

Artia Global Partners’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,440
Closed -$660K – 45
2024
Q3 		$660K Hold
13,440
– – 0.18% 40
2024
Q2 		$606K Sell
13,440
-73,600
-85% -$2.5M 0.12% 43
2024
Q1 		$5.42M Buy
+87,040
New +$5.64M 1.09% 15

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artia Global Partners's IRON Position: Q4 2024 in Review

Artia Global Partners sold out of Disc Medicine (IRON) in Q4 2024, closing a stake of 13,440 shares — an estimated $660K sold.

Artia Global Partners first reported a position in IRON in Q1 2024 and held it in 3 quarters. The position peaked at $5.42M in Q1 2024. 152 funds tracked by Wall St. Rank hold IRON as of Q4 2024.

  • Artia Global Partners reported no remaining Disc Medicine position as of Q4 2024 after selling out during the quarter.
  • Artia Global Partners sold 13,440 Disc Medicine shares in Q4 2024, an estimated $660K.
  • Artia Global Partners first reported a position in Disc Medicine in Q1 2024 and held it in 3 quarters.
  • Artia Global Partners's Disc Medicine position peaked at $5.42M in Q1 2024.
  • 152 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2024.

Based on Artia Global Partners's 13F filing for Q4 2024, filed 14 Feb 2025.